Investors in Akebia Therapeutics (NASDAQ:AKBA) have unfortunately lost 73% over the last ...
Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) shareholders will doubtless be very grateful to see the share price up 31% ...